Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Bonnet

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Investigational New Drugs|May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.
Investigational New Drugs|January 1, 1994
Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group studyV Gupta, E B Thompson, D Stock-Novack, et al.
Cancer Treatment Reports|January 1, 1985
Tamoxifen therapy and colorectal adenocarcinoma: a Southwest Oncology Group studyF J Panettiere, C W Groppe, J W Athens, et al.
Cancer|February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group studyW S Dalton, J J Crowley, S S Salmon, et al.
Investigational New Drugs|February 1, 1990
Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group studyC Karanes, J Crowley, L Sawkar, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Investigational New Drugs|January 1, 1990
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group studyM B Edelstein, J J Crowley, F A Valeriote, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group studyS E Salmon, D Tesh, J Crowley, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Investigational New Drugs|November 11, 1991
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group studyB G Durie, J Crowley, C A Coltman, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Investigational New Drugs|May 1, 1990
Phase II study of fludarabine phosphate in multiple myeloma. A Southwest Oncology Group studyE H Kraut, J J Crowley, M R Grever, et al.
Investigational New Drugs|January 1, 1994
Efficacy of prednisone in refractory multiple myeloma and measurement of glucocorticoid receptors. A Southwest Oncology Group studyV Gupta, E B Thompson, D Stock-Novack, et al.
Cancer Treatment Reports|January 1, 1985
Tamoxifen therapy and colorectal adenocarcinoma: a Southwest Oncology Group studyF J Panettiere, C W Groppe, J W Athens, et al.
Cancer|February 1, 1995
A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group studyW S Dalton, J J Crowley, S S Salmon, et al.
Investigational New Drugs|February 1, 1990
Aclacinomycin A in the treatment of multiple myeloma: a Southwest Oncology Group studyC Karanes, J Crowley, L Sawkar, et al.
Cancer|November 15, 1986
A useful high-dose intermittent schedule of adriamycin and DTIC in the treatment of advanced sarcomasJ H Saiki, L H Baker, S E Rivkin, et al.
Investigational New Drugs|January 1, 1990
A-phase II study of intravenous 6-thioguanine (NSC-752) in multiple myeloma. A Southwest Oncology Group studyM B Edelstein, J J Crowley, F A Valeriote, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 1990
Chemotherapy is superior to sequential hemibody irradiation for remission consolidation in multiple myeloma: a Southwest Oncology Group studyS E Salmon, D Tesh, J Crowley, et al.
Journal of the National Cancer Institute|July 3, 1991
Phase III comparison of doxorubicin and dacarbazine given by bolus versus infusion in patients with soft-tissue sarcomas: a Southwest Oncology Group studyM Zalupski, B Metch, S Balcerzak, et al.
Investigational New Drugs|November 11, 1991
Phase II evaluation of bisantrene in refractory multiple myeloma. A Southwest Oncology Group studyB G Durie, J Crowley, C A Coltman, et al.
Pageof 4